In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine was viable.

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the pharmaceutical company.

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

The Trump administration’s change in foreign corruption case enforcement might have helped the pharma giant which faced corruption investigations in China and Mexico.

Pfizer said Tuesday it does not expect the Trump administration to make major changes to vaccine policy next year even with vaccine skeptic Robert F. Kennedy Jr. as the nominee to run the ...

Pfizer projects 2025 revenues of $61-$64 billion, adjusted EPS of $2.80-$3.00, ... Pfizer Does Not Anticipate Material Changes To US Vaccine Policy From The Incoming Administration In 2025.

Starboard reportedly takes $1 billion stake in Pfizer, seeks changes Provided by Dow Jones Oct 7, 2024, 1:44:00 AM. By Mike Murphy .

Pfizer made changes to its DEI webpage, joining other companies across different industries repositioning their messaging amid President Trump’s dismantling of DEI initiatives.

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer PFE 0.24 % increase; green up pointing triangle and wants the struggling drugmaker to make changes to turn its ...

Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported late Sunday.. Citing unnamed ...